In the BioHarmony Drug Report Database

"Preview" Icon

Nabumetone

Relafen (nabumetone) is a small molecule pharmaceutical. Nabumetone was first approved as Relafen on 1991-12-24. It is used to treat inflammation, osteoarthritis, pain, and rheumatoid arthritis in the USA.

 

Trade Name

 

Relafen
 

Common Name

 

nabumetone
 

ChEMBL ID

 

CHEMBL1070
 

Indication

 

inflammation, osteoarthritis, pain, rheumatoid arthritis
 

Drug Class

 

Cannabinol derivatives

Image (chem structure or protein)

Nabumetone structure rendering